bêta
IA Trial Radar

Les essais cliniques correspondant aux critères pour Diabète sont listés.

Je peux vous aider à comprendre votre état de santé, les traitements ou à trouver des essais cliniques près de chez vous.
Notre outil de recherche ne prend en charge que l'anglais. Pour la recherche et la discussion dans d'autres langues, utilisez l'IA Trial Radar ci-dessus ou sélectionnez les filtres de condition médicale et de lieu ci-dessous.
2 189 résultats trouvés
Affichage des 50 premiers
 
Pathologie
Diabète
×
 
Phase
Phase I
×
 
Titre de l'étude
Statut
Renal Mechanism of Action/Splay vs. TmG (MOA) NCT00726505
Interrompu
Effect Of Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitors on Body Mass Index After 3 Months of Use in Diabetic Patients NCT07367555
Terminé
Une étude pour évaluer la pharmacocinétique et la sécurité entre « BR3006 » et la co-administration de « BR3006A », « BR3006B » et « BR3006C » chez des volontaires adultes sains (Fed) NCT07083401
En recrutement
Étude ouverte et randomisée croisée sur la pharmacocinétique, la pharmacodynamique, la biopotence et la biodisponibilité des capsules d'insuline chez des hommes chinois sains NCT06519604
Actif, ne recrute pas
A Randomized, Double-blind, Placebo-controlled, Sequential Single and Multiple Ascending Doses of YG1699 NCT03953092
Terminé
Teneligliptin and Atorvastatin DDI Study NCT03769870
Terminé
Phase 1 Study in Diabetes Mellitus(Fed) NCT06551740
Terminé
Effects of Selected Statins on Blood Glucose Levels in Healthy Volunteers ([Statins]) NCT07378293
Pas encore en recrutement
Phase 1 Study in Diabetes Mellitus(Fasting) NCT06552182
Terminé
Phase I Clinical Study to Evaluate the Safety and Efficacy of RGB-5088 in Patients With Type 1 Diabetes Mellitus NCT06731218
En recrutement
Effectiveness Study of Pramlintide to Treat Post-Transplant Diabetes Mellitus NCT01165944
Retiré
Novel Type 2 Diabetes Mellitus Preventive Therapies NCT02351323
Terminé
Mesenchymal Stem Cells Transplantation in Newly Diagnosed Type-1 Diabetes Patients (MSCTXT1DM) NCT04078308
Inconnu
Single Ascending Dose Study of MK-1092 in Healthy Participants and in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-1092-001) NCT03170544
TerminéRésultats publiés
The Treatment of Patients With Type 1 Diabetes Mellitus With Autologous Tolerogenic Dendritic Cells NCT05207995
Terminé
Comparison Between Low Carbohydrate Diet and Traditionally Recommended Diabetic Diet in the Treatment of Diabetes Mellitus Type 2. (VÄSTKOST) NCT01005498
Terminé
Multiple Ascending Dose Study of MK-5160 in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-5160-002) NCT03095651
TerminéRésultats publiés
Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Diabetes Mellitus. (BMACD) NCT01832441
Inconnu
Évaluation pharmacocinétique sous-cutanée de l'insuline monomérique et de Lyumjev chez les adultes atteints de diabète de type 1 (SPEED) NCT07090824
En recrutement
A Study of CT-388 in Otherwise Healthy Overweight and Obese Adults and Patients With Type 2 Diabetes Mellitus NCT04838405
Terminé
Study of the Effects of Xenin-25 in Humans With and Without Type 2 Diabetes Mellitus NCT00798915
Terminé
A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus NCT02059564
Inconnu
A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GZR4 in Subjects With Type 2 Diabetes NCT06553248
Terminé
Islet Transplantation Alone (ITA) in Patients With Difficult to Control Type I Diabetes Mellitus Using a Glucocorticoid-free Immunosuppressive Regimen NCT00706420
Actif, ne recrute pas
Chinese Multiple Dose Escalation (MDE) High Dose Study (COTA China PK) NCT05437848
Terminé
In-patient Study in Patients With Type 2 Diabetes Mellitus NCT00259896
Terminé
Investigate Effect of AMG 151 on 24-hour Ambulatory Blood Pressure & Glucose Levels in Type 2 Diabetes Mellitus Subjects NCT01755442
Interrompu
A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes (YKAA) NCT06945406
En recrutement
A Research Study to Look at How Faster Aspart Works in Chinese People With Type 1 Diabetes or Type 2 Diabetes NCT04698018
Terminé
Evaluation of a Diabetes Vaccine in Newly Diagnosed Diabetics NCT00057499
Terminé
Study of the Safety and Efficacy of MK-8521 Compared to Placebo and a Diabetes Drug in Participants With Type 2 Diabetes Mellitus (MK-8521-003) NCT01982630
TerminéRésultats publiés
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Diabetes NCT05003908
Interrompu
Study of the Safety of FG-3019 in Incipient Nephropathy Due to Type 1 or Type 2 Diabetes Mellitus NCT00102297
Terminé
Evaluate HM-002-1005 in Subjects With Type 2 Diabetes Mellitus NCT06498284
Terminé
Autologous Bone Marrow Mononuclear Cells Transplantation in Treating Diabetes Patients NCT00465478
Inconnu
Isoprostane/FMD Study The Effect of Protein Kinase C (PKC) β Specific Inhibitor LY333531 on Oxidant Stress in Patients With Type 2 Diabetes Mellitus NCT00552227
Terminé
Safety Study of BMS-903452 in Healthy Subjects (Panel 1-7) & Relative Bioavailability of the Crystalline and Amorphous Forms of BMS-903452 [Panels 4, 6, 11 & 12(Part A)], and Subjects With Type 2 Diabetes Mellitus (Part B) NCT01240980
Terminé
A Study of TG103 Injection in Overweight/Obese Subjects Without Diabetes NCT04855292
Terminé
cfMSC Therapy for Diabetes NCT07495956
En recrutement
Improving Diabetes Outcomes: a Couples Intervention NCT00250731
Terminé
Multiple Ascending Dose Study of MHS552 in Adults With Type 1 Diabetes Mellitus NCT05272059
Retiré
Personalized Exercise for Adolescents With Diabetes NCT00686283
Terminé
Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes NCT00376038
Terminé
Diabetes Management Personal Trainer NCT00340093
Terminé
A Study Evaluating the Bioequivalence of VIAject®7 Compared to VIAject®25 and Comparing the Pharmacokinetic and Pharmacodynamic Properties of VIAject®7 to Insulin Lispro in Subjects With Type 1 Diabetes Mellitus NCT01235039
Terminé
Home Based Resistance Training For Type 2 Diabetes NCT00221208
Terminé
A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006) NCT07242469
En recrutement
Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of SHR3824 in Type 2 Diabetes Mellitus Patients NCT02346175
Terminé
A Study of Single or Repeated Doses of Glucagon in Participants With Diabetes NCT02806973
TerminéRésultats publiés
A Study of Single and Repeated Doses of Glucagon Administered to Participants With Diabetes NCT02806960
InterrompuRésultats publiés